References
- Greenlee R T, Murray T, Bolden S, et al. Cancer statistics, 2000. CA Cancer J Clin 2000; 50: 7–33
- Coebergh J WW, Janssen-Heijnen M LG, Post P N, et al. Serious co-morbidity among unselected cancer patients newly diagnosed in the Southeastern part of The Netherlands in 1993–1996. J Clin Epidemiol 1999; 52: 1131–6
- Schrijvers C TM, Coebergh J WW, Mackenbach J P. Socioeconomic status and comorbidity among newly diagnosed cancer patients. Cancer 1997; 80: 1482–8
- Eapen L, Villeneuve P J, Levy I G, et al. Comorbid survival among elderly participants of the Canada Health Survey: relevance to prostate cancer screening and treatment. Chronic Dis Can 1998; 19: 84–90
- Albertsen P C, Fryback D G, Storer B E, et al. The impact of co-morbidity on life expectancy among men with localized prostate cancer. J Urol 1996; 156: 127–32
- Kaplan M H, Feinstein A R. The importance of classifying initial co-morbidity in evaluating the outcomes of diabetes mellitus. J Chronic Dis 1974; 27: 387–404
- Greenfield S, Apolone G, McNeil B J, et al. The importance of co-existing disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Med Care 1993; 31: 141–54
- Charlson M E, Pompie P, Ales K L, et al. A new method of classifying co-morbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373–83
- Goldman L. Multifactorial index of cardiac risk in noncardiac surgery. Ten-year status report. J Cardiothorac Anesth 1987; 1: 237–44
- Goldman L, Caldera D L, Nussbaum S R, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977; 297: 845–50
- Post P N, Kil P JM, Hendrikx A JM, et al. Comorbidity in patients with prostate cancer and its relevance to treatment choice. Br J Urol 1999; 84: 652–6
- Dreicer R, Cooper C S, Williams R D. Management of prostate and bladder cancer in the elderly. Urol Clin North Am 1996; 23: 87–97
- Middleton A W. Radical prostatectomy for carcinoma in men more than 69 years old. J Urol 1987; 138: 1185–8
- Yan Y, Carvalhal G F, Catalona W J, et al. Primary treatment choices for men with clinically localized prostate carcinoma detected by screening. Cancer 2000; 88: 1122–30
- Desch C E, Penberthy L, Newschaffer C J, et al. Factors that determine the treatment for local and regional prostate cancer. Med Care 1996; 34: 152–62
- Albertsen P C, Fryback D G, Storer B E, et al. Long-term survival among men with conservatively treated localized prostate cancer. J Am Med Assoc 1995; 275: 626–31